- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Synthetic lethality in lung cancer and translation to clinical therapies ; volume:15 ; number:1 ; day:29 ; month:9 ; year:2016 ; pages:1-16 ; date:12.2016
Molecular cancer ; 15, Heft 1 (29.9.2016), 1-16, 12.2016
- Urheber
-
Leung, Ada W. Y.
- Beteiligte Personen und Organisationen
-
de Silva, Tanya
Bally, Marcel B.
Lockwood, William W.
SpringerLink (Online service)
- DOI
-
10.1186/s12943-016-0546-y
- URN
-
urn:nbn:de:1111-2016110526351
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Leung, Ada W. Y.
- de Silva, Tanya
- Bally, Marcel B.
- Lockwood, William W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Modeling synthetic lethality
Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
Epigenetic synthetic lethality approaches in cancer therapy
Advances in synthetic lethality modalities for glioblastoma multiforme
Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer
Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia
Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
Benchmarking machine learning methods for synthetic lethality prediction in cancer
Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality
Development of synthetic lethality in cancer: molecular and cellular classification
Modeling synthetic lethality
Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
Epigenetic synthetic lethality approaches in cancer therapy
Advances in synthetic lethality modalities for glioblastoma multiforme
Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer
Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia
Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
Benchmarking machine learning methods for synthetic lethality prediction in cancer
Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality
Development of synthetic lethality in cancer: molecular and cellular classification
Modeling synthetic lethality
Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
Epigenetic synthetic lethality approaches in cancer therapy
Advances in synthetic lethality modalities for glioblastoma multiforme
Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer
Telomere dysfunction and synthetic lethality in chronic lymphocytic leukemia
Exploiting genetic vulnerabilities for BAP1 loss by synthetic lethality
Synthetic lethality in malignant pleural mesothelioma with PARP1 inhibition
Wnt signaling inhibition confers induced synthetic lethality to PARP inhibitors
Benchmarking machine learning methods for synthetic lethality prediction in cancer
Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality